Commonwealth Financial Services LLC Purchases New Shares in ARK Genomic Revolution ETF $ARKG

Commonwealth Financial Services LLC purchased a new stake in ARK Genomic Revolution ETF (BATS:ARKG) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 28,765 shares of the company’s stock, valued at approximately $833,000.

A number of other hedge funds and other institutional investors have also modified their holdings of ARKG. Sunbelt Securities Inc. boosted its position in shares of ARK Genomic Revolution ETF by 734.3% in the 3rd quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock valued at $31,000 after purchasing an additional 984 shares during the period. Strategic Wealth Investment Group LLC purchased a new stake in ARK Genomic Revolution ETF in the 2nd quarter worth about $38,000. AlphaCore Capital LLC purchased a new stake in ARK Genomic Revolution ETF in the 4th quarter worth about $39,000. Advisory Services Network LLC purchased a new stake in ARK Genomic Revolution ETF in the 3rd quarter worth about $58,000. Finally, Allworth Financial LP lifted its stake in ARK Genomic Revolution ETF by 39.9% in the 4th quarter. Allworth Financial LP now owns 2,061 shares of the company’s stock worth $60,000 after acquiring an additional 588 shares in the last quarter.

ARK Genomic Revolution ETF Price Performance

Shares of ARK Genomic Revolution ETF stock opened at $30.53 on Friday. The stock has a 50-day moving average price of $28.32 and a 200 day moving average price of $29.33. ARK Genomic Revolution ETF has a 1 year low of $20.26 and a 1 year high of $34.39.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.